For the quarter ending 2026-04-04, IRIX had -$1,433K decrease in cash & cash equivalents over the period. -$1,436K in free cash flow.
| Cash Flow | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 |
|---|---|---|---|---|
| Net loss | -524 | -184 | -1,573 | -2,680 |
| Loss on inventory write-down | - | 0 | 823 | - |
| Loss on extinguishment of convertible note payable | 0 | 0 | 0 | -1,335 |
| Depreciation and amortization | 100 | 151 | 110 | 262 |
| Amortization of operating lease right-of-use assets | 272 | 271 | 256 | 497 |
| Accretion of original issue discount | 0 | 0 | 0 | -58 |
| Amortization of debt issuance costs | 30 | 30 | 30 | 109 |
| Stock-based compensation | 211 | 213 | 92 | 470 |
| Accounts receivable | -769 | 481 | -5 | 1,186 |
| Receivable from related party | -360 | -466 | -495 | 450 |
| Inventories | 1,448 | 576 | -311 | -2,382 |
| Prepaid expenses and other current assets | 446 | 140 | 37 | -339 |
| Other long-term assets | 62 | -72 | -77 | -121 |
| Accounts payable | 368 | 976 | -905 | -2,025 |
| Payable to related party | 184 | -96 | -222 | -174 |
| Accrued compensation | -622 | 408 | 71 | 189 |
| Accrued expenses | 84 | 16 | 8 | 107 |
| Deferred revenue | -499 | -455 | -440 | -670 |
| Operating lease liabilities | -286 | -283 | -313 | -512 |
| Other liabilities | 174 | 201 | 54 | 282 |
| Net cash used in operating activities | -1,335 | 589 | -1,158 | -1,546 |
| Acquisition of property and equipment | 101 | 106 | 13 | 24 |
| Cash paid for debt issuance costs | - | 0 | 0 | - |
| Net cash used in investing activities | -101 | -106 | -13 | -24 |
| Proceeds for stock option exercises | - | 0 | 0 | - |
| Payments on convertible note payable | - | 0 | 0 | 3,961 |
| Proceeds from issuance of series b convertible preferred stock | - | 0 | 0 | 6,000 |
| Proceeds from issuance of convertible note payable | 0 | 0 | 0 | 4,000 |
| Payments on note payable | 0 | - | - | - |
| Proceeds from issuance of series b preferred stock | 0 | - | - | - |
| Taxes paid related to net share settlements of equity awards | 1 | 27 | 34 | 14 |
| Net cash provided by (used in) financing activities | -1 | -27 | -34 | 6,025 |
| Effect of foreign exchange rate changes | 4 | -1 | 0 | -64 |
| Net increase (decrease) in cash and cash equivalents | -1,433 | 455 | -1,205 | 4,391 |
| Cash and cash equivalents, beginning of year | 6,028 | 5,573 | 2,387 | - |
| Cash and cash equivalents, end of year | 4,595 | 6,028 | 5,573 | - |
IRIDEX CORP (IRIX)
IRIDEX CORP (IRIX)